0.0001
price down icon33.64%   -0.0602
 
loading

Finanzdaten der Paxmedica Inc-Aktie (PXMD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
15.87%
3.6902
4.3861 4.3645 3.3579 4.0367
Operating Income/Loss
15.87%
-3.6902
-4.3861 -4.3645 -3.3579 -4.0367
Nonoperating Income/Loss
99.80%
-0.00302
-1.5343 -0.6847 -0.1283 0.2029
Income/Loss From Continuing Operations Before Tax
37.62%
-3.6932
-5.9207 -5.0492 -3.4863 -3.8337
Income/Loss From Continuing Operations After Tax
37.62%
-3.6932
-5.9207 -5.0492 -3.4863 -3.8337
Net Income/Loss
37.62%
-3.6932
-5.9205 -5.0492 -3.4863 -3.8337
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
823.41%
7.4183
0.8034 0.9717 14.67 12.64
Diluted Average Shares
823.41%
7.4183
0.8034 0.9717 14.67 12.64
Basic Earnings Per Share
114.75%
-0.50
3.39 -5.20 -0.24 -0.30
Diluted Earnings Per Share
114.75%
-0.50
3.39 -5.20 -0.24 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
Kapitalisierung:     |  Volumen (24h):